A rat experiment found improved skin perfusion after adding vatinoxan to medetomidine–midazolam sedation. It did not isolate a midazolam effect.
The investigators measured arterial pressure, pulse, laser-Doppler skin flow, and tissue oxygen saturation in male Wistar rats. Vatinoxan was associated with lower pressure and improved skin flow and oxygenation. Added fentanyl did not significantly change the reported outcomes.
These results show why a higher systemic pressure need not imply better peripheral perfusion under a vasoconstricting regimen.
Midazolam remained part of the sedation background. The comparison therefore cannot establish what its removal would do or attribute the improvement to reversal of benzodiazepine action. Vatinoxan and flumazenil have different targets.
Only male rats were studied. Cutaneous measurements are not direct measurements of human cerebral perfusion or tissue injury. The findings concern refinement of a laboratory-animal regimen, with species, exposure, co-medication, and endpoint differences limiting translation to a mixed human intoxication.
Original analysis of the supplied journal article, identified as PMC13235014.